The incidence of unexpected gynaecological malignancies in hysterectomies carried out for benign indications

References

• Bansal N, Herzog TJ, Burke W, Cohen CJ, Wright JD. 2008. The utility of preoperative endometrial sampling for the detection of uterine sarcomas. Gynecologic Oncology 110:43–48.
   PubMed Web of Science ®Google Scholar
• Benoit AG, Krepart GV, Lotocki RJ. 1984. Results of prior cytologic screening in patients with a diagnosis of Stage I carcinoma of the cervix. American Journal of Obstetrics and Gynecology 148:690–694.
   PubMed Web of Science ®Google Scholar
• Bora BB. 2018. TC Sağlık Bakanlığı Sağlık İstatistikleri Yıllığı In: Birinci Ş, Ülgü MM, Bora Başara B, Soytutan Çİ, Aygün A, Özdemir TA, editors. Ankara, Sağlık Bilgi Sistemleri Genel Müdürlüğü, Sağlık Bakanlığı Yayınları, 38–42.
   Google Scholar
• Buscema J, McLellan R. 2015. Uterine sarcomas. In: Bieber EJ, Sanfilippo JS, Horowitz IR, Shafi MI, editors. Clinical Gynecology. Cambridge: Cambridge University Press; 769–778.
   Google Scholar
• Castellano T, Ding K, Moore KN, Landrum LM. 2019. Simple hysterectomy for cervical cancer: risk factors for failed screening and deviation from screening guidelines. Journal of Lower Genital Tract Disease 23:124–128.
   PubMed Web of Science ®Google Scholar
• Desai VB, Wright JD, Gross CP, Lin H, Boscoe FP, Hutchison LM, et al. 2019. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy. American Journal of Obstetrics and Gynecology 221:39.e1–39.e14.
   Web of Science ®Google Scholar
• Dodge JE, Covens AL, Lacchetti C, Elit LM, Le T, Devries-Aboud M, Gynecology Cancer Disease Site Group, et al. 2012. Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis. Gynecologic Oncology 126:157–166.
   PubMed Web of Science ®Google Scholar
• Goldstein SR, Nachtigall M, Snyder JR, Nachtigall L. 1990. Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. American Journal of Obstetrics and Gynecology 163:119–123.
   PubMed Web of Science ®Google Scholar
• Hartmann E, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, et al. 2017. Management of uterine fibroids. Comparative effectiveness review no. 195. AHRQ Publication, 18.
   Google Scholar
• Havrilesky LJ, Maxwell GL, Myers ER. 2009. Cost effectiveness analysis of annual screening strategies for endometrial cancer. American Journal of Obstetrics and Gynecology 200:e1.
   PubMed Web of Science ®Google Scholar
• Iatrakis G, Diakakis I, Kourounis G, Sakellaropoulos G, Rammos G, Ladopoulos J, et al. 1997. Postmenopausal uterine bleeding. Clinical and Experimental Obstetrics and Gynecology 24:157–157.
   PubMedGoogle Scholar
• Karlsson B, Granberg S, Wikland M, Ylöstalo P, Torvid K, Marsal K, et al. 1995. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding—a Nordic multicenter study. American Journal of Obstetrics and Gynecology 172:1488–1494.
   PubMed Web of Science ®Google Scholar
• Leibsohn S, d'Ablaing G, Mishell DR, Schlaerth JB. 1990. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. American Journal of Obstetrics and Gynecology 162:968–976.
   PubMed Web of Science ®Google Scholar
• Mahnert N, Morgan D, Campbell D, Johnston C, As-Sanie S. 2015. Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications. Obstetrics and Gynecology 125:397–405.
   PubMed Web of Science ®Google Scholar
• Parsons P, Pedersen R, Richardson DL, Kho KA. 2018. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications. European Journal of Obstetrics & Gynecology and Reproductive Biology 223:108–112.
   PubMed Web of Science ®Google Scholar
• Stovall G, Photopulos J, Poston M, Ling W, Sandles G. 1991. Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstetrics and Gynecology 77:954–956.
   PubMed Web of Science ®Google Scholar
• Timmermans A, Opmeer C, Khan S, Bachmann M, Epstein E, Clark J, et al. 2010. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstetrics and Gynecology 116:160–167.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration 2014. Quantitative assessment of the prevalence of unsuspected uterine sarcoma in women undergoing treatment of uterine fibroids: summary and key findings. Silver Spring, MD. Accessed 2018 August 26. Available at: https://www.fda.gov/downloads/medicaldevices/safety/alertsandnotices/ucm393589.pdf
   Google Scholar
• Van Den Haak L, de Kroon D, Warmerdam I, Siebers G, Rhemrev P, Nieboer E, et al. 2019. Incidence and groups at risk for unexpected uterine leiomyosarcoma: a Dutch nationwide cohort study. Archives of Gynecology and Obstetrics 299:159–165.
   PubMed Web of Science ®Google Scholar
• Wagner P, Kommoss F, Kommoss S, Hartkopf D, Pasternak I, Oberlechner E, et al. 2019. Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease. Gynecologic Oncology 153:49–54.
   PubMed Web of Science ®Google Scholar
• Walboomers M, Jacobs V, Manos M, Bosch X, Kummer A, Shah V, et al. 1999. Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology 189:12–19.
   PubMed Web of Science ®Google Scholar
• Yilmaz T, Senocak C, Topdagi E, Yildiz A, Kumtepe Y. 2020. Incidence of occult malignancies identified during hysterectomies performed for benign indications. Journal of Gynecology Obstetrics and Human Reproduction 49:101620.
   PubMed Web of Science ®Google Scholar
• Yuk S, Kim Y, Kim SH, Lee JH. 2016. The incidence of unexpected uterine malignancy in women undergoing hysterectomy for a benign condition: a national population-based study. Annals of Surgical Oncology 23:4029–4034.
   PubMed Web of Science ®Google Scholar